BRCA MUTATED PANCREATIC CANCER

Clinical trials for BRCA MUTATED PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new BRCA MUTATED PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for BRCA MUTATED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New safety data on LYNPARZA for pancreatic cancer patients with BRCA mutation

Disease control Completed

This study looked at the safety of LYNPARZA (olaparib) when used as a maintenance treatment after platinum-based chemotherapy in 130 patients with BRCA-mutated pancreatic cancer that could not be surgically removed. Researchers tracked side effects like bone marrow problems, lung…

Matched conditions: BRCA MUTATED PANCREATIC CANCER

Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

BRCA MUTATED PANCREATIC CANCER

Get alerted when new BRCA MUTATED PANCREATIC CANCER trials appear

New safety data on LYNPARZA for pancreatic cancer patients with BRCA mutation